SCHEMBL23918225

SCHEMBL23918225

Clc1ccc(-c2cc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)cc3c2Oc2cc4ccccc4cc2O3)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 2/20 0.38
MAP4K4 O95819 1/20 0.36
CYP1A2 P05177 2/20 0.33
KDM4E B2RXH2 5/20 0.32
ALDH1A1 P00352 4/20 0.32
TDP1 Q9NUW8 2/20 0.32
GAA P10253 2/20 0.32
MAPK1 P28482 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
POLB P06746 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 3/20 0.31
MAPT P10636 2/20 0.31
HPGD P15428 2/20 0.31
MEN1 O00255 2/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22180406 0.82 BCHE (0.39)
SCHEMBL26306457 0.72 CYP2A6 (0.48) CYP1A2HTTKMT2AMEN1
SCHEMBL26306339 0.72 CYP2A6 (0.48) CYP1A2KDM4EALDH1A1TDP1GAA
SCHEMBL28653338 0.72 PTPN1 (0.40) GPR84KDM4EALDH1A1L3MBTL1SMN1; SMN2
SCHEMBL16837503 0.72 CYP1A2 (0.64) MAP4K4CYP1A2KDM4EALDH1A1TDP1
SCHEMBL20871977 0.72 CYP1A2 (0.64) MAP4K4CYP1A2KDM4EALDH1A1TDP1
SCHEMBL1702246 0.72 CYP1A2 (0.64) MAP4K4CYP1A2KDM4EALDH1A1TDP1
SCHEMBL14340293 0.72 CYP1A2 (0.64) MAP4K4CYP1A2KDM4EALDH1A1TDP1
SCHEMBL25915229 0.70 KDM4E (0.36) GPR84KDM4EMAPK1
SCHEMBL25915299 0.70 KDM4E (0.36) GPR84KDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320258-A1 COMPOUND FOR AN ORGANIC ELECTRIC ELEMENT, AN ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320258-A1 COMPOUND FOR AN ORGANIC ELECTRIC ELEMENT, AN ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF PIEZO1, OR10J3, OCIAD1 GPR84 4162/4885MAP4K4 2393/4885CYP1A2 1389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.